Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis (original) (raw)

• Agadjanyan MG, Ghochikyan A, Petrushina I et al (2005) Prototype Alzheimer’s disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide. J Immunol 174:1580–1586
  PubMed CAS Google Scholar
• Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21:383–421
  Article PubMed CAS Google Scholar
• Alaupovic P (1982) The role of apolipoproteins in lipid transport processes. Ric Clin Lab 12:3–21
  PubMed CAS Google Scholar
• Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 27:9115–9129
  Article PubMed CAS Google Scholar
• Asuni AA, Boutajangout A, Scholtzova H et al (2006) Vaccination of Alzheimer’s model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages. Eur J Neurosci 24:2530–2542
  Article PubMed Google Scholar
• Bard F, Barbour R, Cannon C et al (2003) Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer’s disease-like neuropathology. Proc Natl Acad Sci USA 100:2023–2028
  Article PubMed CAS Google Scholar
• Bard F, Cannon C, Barbour R et al (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916–919
  Article PubMed CAS Google Scholar
• Bayer AJ, Bullock R, Jones RW et al (2005) Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD. Neurology 64:94–101
  PubMed CAS Google Scholar
• Boche D, Donald J, Love S et al (2010) Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer’s disease. Acta Neuropathol 120:13–20
  Article PubMed CAS Google Scholar
• Boche D, Nicoll JA (2008) The role of the immune system in clearance of abeta from the brain. Brain Pathol 18:267–278
  Article PubMed Google Scholar
• Boche D, Zotova E, Weller RO et al (2008) Consequence of Abeta immunization on the vasculature of human Alzheimer’s disease brain. Brain 131:3299–3310
  Article PubMed CAS Google Scholar
• Bombois S, Maurage CA, Gompel M et al (2007) Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia. Arch Neurol 64:583–587
  Article PubMed Google Scholar
• Borchelt DR, Ratovitski T, van Lare J et al (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939–945
  Article PubMed CAS Google Scholar
• Boyles JK, Zoellner CD, Anderson LJ et al (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83:1015–1031
  Article PubMed CAS Google Scholar
• Brendza RP, Bacskai BJ, Cirrito JR et al (2005) Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest 115:428–433
  PubMed CAS Google Scholar
• Buttini M, Masliah E, Barbour R et al (2005) Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer’s disease. J Neurosci 25:9096–9101
  Article PubMed CAS Google Scholar
• Carare RO, Bernardes-Silva M, Newman TA et al (2008) Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 34:131–144
  Article PubMed CAS Google Scholar
• Chauhan NB (2003) Membrane dynamics, cholesterol homeostasis, and Alzheimer’s disease. J Lipid Res 44:2019–2029
  Article PubMed CAS Google Scholar
• Clapham R, O’Sullivan E, Weller RO, Carare RO (2010) Cervical lymph nodes are found in direct relationship with the internal carotid artery: significance for the lymphatic drainage of the brain. Clin Anat 23:43–47
  PubMed CAS Google Scholar
• Clavaguera F, Bolmont T, Crowther RA et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909–913
  Article PubMed CAS Google Scholar
• Davies CA, Mann DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease. J Neurol Sci 78:151–164
  Article PubMed CAS Google Scholar
• DeMattos RB, Bales KR, Cummins DJ et al (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 98:8850–8855
  Article PubMed CAS Google Scholar
• DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer’s disease. Science 295:2264–2267
  Article PubMed CAS Google Scholar
• DeMattos RB, Bales KR, Parsadanian M et al (2002) Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer’s disease. J Neurochem 81:229–236
  Article PubMed CAS Google Scholar
• Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55:250–256
  Article PubMed Google Scholar
• Ferrer I, Boada Rovira M, Sanchez Guerra ML, Rey MJ, Costa-Jussa F (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer’s disease. Brain Pathol 14:11–20
  Article PubMed CAS Google Scholar
• Fidani L, Rooke K, Chartier-Harlin MC et al (1992) Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer’s disease: identification of a further family with APP717 Val→Ile. Hum Mol Genet 1:165–168
  Article PubMed CAS Google Scholar
• Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
  Article PubMed CAS Google Scholar
• Games D, Adams D, Alessandrini R et al (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523–527
  Article PubMed CAS Google Scholar
• Games D, Bard F, Grajeda H et al (2000) Prevention and reduction of AD-type pathology in PDAPP mice immunized with A beta 1–42. Ann N Y Acad Sci 920:274–284
  Article PubMed CAS Google Scholar
• Gentleman SM, Leclercq PD, Moyes L et al (2004) Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 146:97–104
  Article PubMed CAS Google Scholar
• Gilman S, Koller M, Black RS et al (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64:1553–1562
  Article PubMed CAS Google Scholar
• Gong Y, Chang L, Viola KL et al (2003) Alzheimer’s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100:10417–10422
  Article PubMed CAS Google Scholar
• Greenberg SM (1998) Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 51:690–694
  PubMed CAS Google Scholar
• Griffin WS (2006) Inflammation and neurodegenerative diseases. Am J Clin Nutr 83:470S–474S
  PubMed CAS Google Scholar
• Griffin WS, Sheng JG, Royston MC et al (1998) Glial-neuronal interactions in Alzheimer’s disease: the potential role of a ‘cytokine cycle’ in disease progression. Brain Pathol 8:65–72
  Article PubMed CAS Google Scholar
• Haltia M, Viitanen M, Sulkava R et al (1994) Chromosome 14-encoded Alzheimer’s disease: genetic and clinicopathological description. Ann Neurol 36:362–367
  Article PubMed CAS Google Scholar
• Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 12:383–388
  Article PubMed CAS Google Scholar
• Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
  Article PubMed CAS Google Scholar
• Heston LL, Mastri AR (1977) The genetics of Alzheimer’s disease: associations with hematologic malignancy and Down’s syndrome. Arch Gen Psychiatry 34:976–981
  PubMed CAS Google Scholar
• Hock C, Konietzko U, Streffer JR et al (2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer’s disease. Neuron 38:547–554
  Article PubMed CAS Google Scholar
• Holcomb L, Gordon MN, McGowan E et al (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97–100
  Article PubMed CAS Google Scholar
• Holmes C, Boche D, Wilkinson D et al (2008) Long term effect of Abeta42 immunization in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372:216–223
  Article PubMed CAS Google Scholar
• Holtzman DM, Bales KR, Wu S et al (1999) Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer’s disease. J Clin Invest 103:R15–R21
  Article PubMed CAS Google Scholar
• Hsiao K, Chapman P, Nilsen S et al (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99–102
  Article PubMed CAS Google Scholar
• Istrin G, Bosis E, Solomon B (2006) Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide. J Neurosci Res 84:434–443
  Article PubMed CAS Google Scholar
• Janus C, Pearson J, McLaurin J et al (2000) Abeta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease. Nature 408:979–982
  Article PubMed CAS Google Scholar
• Kalaria RN (1999) Microglia and Alzheimer’s disease. Curr Opin Hematol 6:15–24
  Article PubMed CAS Google Scholar
• Karlinsky H, Vaula G, Haines JL et al (1992) Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer’s disease and a missense mutation in codon 717 of the beta-amyloid precursor protein gene. Neurology 42:1445–1453
  PubMed CAS Google Scholar
• Kim HD, Cao Y, Kong FK et al (2005) Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF. Vaccine 23:2977–2986
  Article PubMed CAS Google Scholar
• Korwek KM, Trotter JH, Ladu MJ, Sullivan PM, Weeber EJ (2009) ApoE isoform-dependent changes in hippocampal synaptic function. Mol Neurodegener 4:21
  Article PubMed CAS Google Scholar
• Krugers HJ, Mulder M, Korf J et al (1997) Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. Neuroreport 8:2505–2510
  Article PubMed CAS Google Scholar
• Lassmann H (1996) Patterns of synaptic and nerve cell pathology in Alzheimer’s disease. Behav Brain Res 78:9–14
  Article PubMed CAS Google Scholar
• Lee SJ, Liyanage U, Bickel PE et al (1998) A detergent-insoluble membrane compartment contains A beta in vivo. Nat Med 4:730–734
  Article PubMed CAS Google Scholar
• Lemere CA, Masliah E (2010) Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat Rev Neurol 6:108–119
  Article PubMed CAS Google Scholar
• Lemere CA, Spooner ET, LaFrancois J et al (2003) Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice. Neurobiol Dis 14:10–18
  Article PubMed CAS Google Scholar
• Levi O, Lutjohann D, Devir A et al (2005) Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation. J Neurochem 95:987–997
  Article PubMed CAS Google Scholar
• Lombardo JA, Stern EA, McLellan ME et al (2003) Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. J Neurosci 23:10879–10883
  PubMed CAS Google Scholar
• Lowe J, Mirra SS, Hyman BT, Dickson DW (2008) Ageing and dementia. In: Love S, Louis DN, Ellison DW (eds) Greenfield’s neuropathology, 8th edn. Edward Arnold Ltd, London, pp 1031–1152
  Google Scholar
• Manea M, Mezo G, Hudecz F, Przybylski M (2004) Polypeptide conjugates comprising a beta-amyloid plaque-specific epitope as new vaccine structures against Alzheimer’s disease. Biopolymers 76:503–511
  Article PubMed CAS Google Scholar
• Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer’s disease. Histol Histopathol 10:509–519
  PubMed CAS Google Scholar
• Masliah E, Hansen L, Adame A et al (2005) Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 64:129–131
  PubMed CAS Google Scholar
• Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA (1991) Cortical and subcortical patterns of synaptophysin like immunoreactivity in Alzheimer’s disease. Am J Pathol 138:235–246
  PubMed CAS Google Scholar
• Mauch DH, Nagler K, Schumacher S et al (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354–1357
  Article PubMed CAS Google Scholar
• McDonald JM, Savva GM, Brayne C et al (2010) The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133:1328–1341
  Article Google Scholar
• McGeer PL, Itagaki S, Tago H, McGeer EG (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79:195–200
  Article PubMed CAS Google Scholar
• McLaurin J, Cecal R, Kierstead ME et al (2002) Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4–10 and inhibit cytotoxicity and fibrillogenesis. Nat Med 8:1263–1269
  Article PubMed CAS Google Scholar
• Morgan D, Diamond DM, Gottschall PE et al (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease. Nature 408:982–985
  Article PubMed CAS Google Scholar
• Mouri A, Noda Y, Hara H et al (2007) Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J 21:2135–2148
  Article PubMed CAS Google Scholar
• Mrak RE, Griffin WS (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26:349–354
  Article PubMed CAS Google Scholar
• Mullan M, Crawford F, Axelman K et al (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1:345–347
  Article PubMed CAS Google Scholar
• Mullan M, Houlden H, Windelspecht M et al (1992) A locus for familial early-onset Alzheimer’s disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet 2:340–342
  Article PubMed CAS Google Scholar
• Naruse S, Igarashi S, Kobayashi H et al (1991) Mis-sense mutation Val–Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer’s disease. Lancet 337:978–979
  Article PubMed CAS Google Scholar
• Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 68:1–14
  Article PubMed CAS Google Scholar
• Nichol K, Deeny SP, Seif J, Camaclang K, Cotman CW (2009) Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimer’s Dement 5:287–294
  Article CAS Google Scholar
• Nicoll JA, Barton E, Boche D et al (2006) Abeta species removal after Abeta42 immunization. J Neuropathol Exp Neurol 65:1040–1048
  Article PubMed CAS Google Scholar
• Nicoll JA, McCarron MO (2001) APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage. Amyloid 8(Suppl 1):51–55
  PubMed CAS Google Scholar
• Nicoll JA, Wilkinson D, Holmes C et al (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9:448–452
  Article PubMed CAS Google Scholar
• Nicoll JA, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller RO (2004) Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease. Pro-CAA position statement. Neurobiol Aging 25:589–597 (discussion 603–604)
  Article PubMed CAS Google Scholar
• Nwosu I, Gairhe S, Struble RG, Nathan BP (2008) Impact of apoE deficiency during synaptic remodeling in the mouse olfactory bulb. Neurosci Lett 441:282–285
  Article PubMed CAS Google Scholar
• Oddo S, Vasilevko V, Caccamo A et al (2006) Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281:39413–39423
  Article PubMed CAS Google Scholar
• Oh JY, Nam YJ, Jo A et al (2010) Apolipoprotein (APOE) mRNA is transported to dendrites and may have a role in synaptic structural plasticity. J Neurochem [Epub ahead of print] 2010 April 28. doi:10.1111/j.1471-4159.2010.06773
• Orgogozo JM, Gilman S, Dartigues JF et al (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61:46–54
  PubMed CAS Google Scholar
• Patton RL, Kalback WM, Esh CL et al (2006) Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer’s disease patients: a biochemical analysis. Am J Pathol 169:1048–1063
  Article PubMed CAS Google Scholar
• Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6:193–201
  Article PubMed Google Scholar
• Pfeifer M, Boncristiano S, Bondolfi L et al (2002) Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298:1379
  Article PubMed CAS Google Scholar
• Poirier J (2000) Apolipoprotein E and Alzheimer’s disease. A role in amyloid catabolism. Ann N Y Acad Sci 924:81–90
  Article PubMed CAS Google Scholar
• Prada CM, Garcia-Alloza M, Betensky RA et al (2007) Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci 27:1973–1980
  Article PubMed CAS Google Scholar
• Pride M, Seubert P, Grundman M et al (2008) Progress in the active immunotherapeutic approach to Alzheimer’s disease: clinical investigations into AN1792-associated meningoencephalitis. Neurodegener Dis 5:194–196
  Article PubMed CAS Google Scholar
• Qu B, Rosenberg RN, Li L, Boyer PJ, Johnston SA (2004) Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch Neurol 61:1859–1864
  Article PubMed Google Scholar
• Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119–145
  Article PubMed CAS Google Scholar
• Roher AE, Kuo YM, Esh C et al (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer’s disease. Mol Med 9:112–122
  PubMed Google Scholar
• Rovelet-Lecrux A, Hannequin D, Raux G et al (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24–26
  Article PubMed CAS Google Scholar
• Salloway S, Sperling R, Gilman S et al (2009) A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73:2061–2070
  Article PubMed CAS Google Scholar
• Sato N, Imaizumi K, Manabe T et al (2001) Increased production of beta-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J Biol Chem 276:2108–2114
  Article PubMed CAS Google Scholar
• Schellenberg GD, Bird TD, Wijsman EM et al (1992) Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science 258:668–671
  Article PubMed CAS Google Scholar
• Schenk D, Barbour R, Dunn W et al (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173–177
  Article PubMed CAS Google Scholar
• Schenk D, Hagen M, Seubert P (2004) Current progress in beta-amyloid immunotherapy. Curr Opin Immunol 16:599–606
  Article PubMed CAS Google Scholar
• Scolding NJ, Joseph F, Kirby PA et al (2005) Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128:500–515
  Article PubMed Google Scholar
• Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298:789–791
  Article PubMed CAS Google Scholar
• Serrano-Pozo A, Williams MW, Ferrer I et al (2010) Beneficial effect of human anti-Aβ active immunization on neurite morphology and tau pathology. Brain 133:1312–1327
  Google Scholar
• Shankar GM, Bloodgood BL, Townsend M et al (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866–2875
  Article PubMed CAS Google Scholar
• Sigurdsson EM (2009) Tau-focused immunotherapy for Alzheimer’s disease and related tauopathies. Curr Alzheimer Res 6:446–450
  Article PubMed CAS Google Scholar
• Sigurdsson EM, Knudsen E, Asuni A et al (2004) An attenuated immune response is sufficient to enhance cognition in an Alzheimer’s disease mouse model immunized with amyloid-beta derivatives. J Neurosci 24:6277–6282
  Article PubMed CAS Google Scholar
• Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T (2001) Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer’s disease-associated pathology in transgenic mice. Am J Pathol 159:439–447
  PubMed CAS Google Scholar
• Sleegers K, Brouwers N, Gijselinck I et al (2006) APP duplication is sufficient to cause early onset Alzheimer’s dementia with cerebral amyloid angiopathy. Brain 129:2977–2983
  Article PubMed Google Scholar
• Solomon B, Koppel R, Frankel D, Hanan-Aharon E (1997) Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci USA 94:4109–4112
  Article PubMed CAS Google Scholar
• Sorbi S, Nacmias B, Forleo P et al (1993) APP717 and Alzheimer’s disease in Italy. Nat Genet 4:10
  Article PubMed CAS Google Scholar
• St George-Hyslop PH, Tanzi RE, Polinsky RJ et al (1987) The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235:885–890
  Article PubMed CAS Google Scholar
• Strittmatter WJ, Saunders AM, Schmechel D et al (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977–1981
  Article PubMed CAS Google Scholar
• Sturchler-Pierrat C, Abramowski D, Duke M et al (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287–13292
  Article PubMed CAS Google Scholar
• Sze CI, Troncoso JC, Kawas C et al (1997) Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 56:933–944
  Article PubMed CAS Google Scholar
• Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572–580
  Article PubMed CAS Google Scholar
• Tomic JL, Pensalfini A, Head E, Glabe CG (2009) Soluble fibrillar oligomer levels are elevated in Alzheimer’s disease brain and correlate with cognitive dysfunction. Neurobiol Dis 35:352–358
  Article PubMed CAS Google Scholar
• Van Broeckhoven C, Backhovens H, Cruts M et al (1992) Mapping of a gene predisposing to early-onset Alzheimer’s disease to chromosome 14q24.3. Nat Genet 2:335–339
  Article PubMed Google Scholar
• van Helmond Z, Boche D, Nicoll J et al (2009) Oligomeric A beta levels following A beta(42) immunisation. Neuropathol Appl Neurobiol 35:25
  Google Scholar
• Veinbergs I, Jung MW, Young SJ et al (1998) Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice. Neurosci Lett 249:71–74
  Article PubMed CAS Google Scholar
• Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539
  Article PubMed CAS Google Scholar
• Weller RO (2005) Drainage pathways of CSF and interstitial fluid. In: Kalimo H (ed) Cerebrovascular diseases. ISN Neuropath Press, Basel, pp 50–55
  Google Scholar
• Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102
  Article PubMed CAS Google Scholar
• Weller RO, Djuanda E, Yow HY, Carare RO (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117:1–14
  Article PubMed CAS Google Scholar
• Weller RO, Galea I, Carare RO, Minagar A (2009) Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis. Pathophysiology [Epub ahead of print] 2009 Nov 30. doi:10.1016/j.pathophys.2009.10.007
• Weninger SC, Yankner BA (2001) Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat Med 7:527–528
  Article PubMed CAS Google Scholar
• Wharton SB, O’Callaghan JP, Savva GM et al (2009) Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia. Dement Geriatr Cogn Disord 27:465–473
  Article PubMed CAS Google Scholar
• Wilcock DM, Gharkholonarehe N, Van Nostrand WE et al (2009) Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer’s disease. J Neurosci 29:7957–7965
  Article PubMed CAS Google Scholar
• Wilcock DM, Rojiani A, Rosenthal A et al (2004) Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflamm 1:24
  Article CAS Google Scholar
• Wisniewski T, Konietzko U (2008) Amyloid-beta immunisation for Alzheimer’s disease. Lancet Neurol 7:805–811
  Article PubMed CAS Google Scholar
• Wolfe MS, De Los Angeles J, Miller DD, Xia W, Selkoe DJ (1999) Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer’s disease. Biochemistry 38:11223–11230
  Article PubMed CAS Google Scholar
• Yoshioka K, Miki T, Katsuya T, Ogihara T, Sakaki Y (1991) The 717Val–Ile substitution in amyloid precursor protein is associated with familial Alzheimer’s disease regardless of ethnic groups. Biochem Biophys Res Commun 178:1141–1146
  Article PubMed CAS Google Scholar
• Zetterberg H, Mattsson N, Shaw LM, Blennow K (2010) Biochemical markers in Alzheimer’s disease clinical trials. Biomark Med 4:91–98
  Article PubMed CAS Google Scholar